Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

An open trial of citalopram in adolescents with post-traumatic stress disorder.

Seedat S, Lockhat R, Kaminer D, Zungu-Dirwayi N, Stein DJ.

Int Clin Psychopharmacol. 2001 Jan;16(1):21-5.

PMID:
11195256
2.

Open-label trial of escitalopram in the treatment of posttraumatic stress disorder.

Robert S, Hamner MB, Ulmer HG, Lorberbaum JP, Durkalski VL.

J Clin Psychiatry. 2006 Oct;67(10):1522-6.

PMID:
17107242
3.

Treatment of chronic posttraumatic stress disorder in combat veterans with citalopram: an open trial.

English BA, Jewell M, Jewell G, Ambrose S, Davis LL.

J Clin Psychopharmacol. 2006 Feb;26(1):84-8.

PMID:
16415713
4.

Quetiapine as an adjunctive treatment for post-traumatic stress disorder: an 8-week open-label study.

Ahearn EP, Mussey M, Johnson C, Krohn A, Krahn D.

Int Clin Psychopharmacol. 2006 Jan;21(1):29-33.

PMID:
16317314
5.

Adjunctive risperidone treatment in post-traumatic stress disorder: a preliminary controlled trial of effects on comorbid psychotic symptoms.

Hamner MB, Faldowski RA, Ulmer HG, Frueh BC, Huber MG, Arana GW.

Int Clin Psychopharmacol. 2003 Jan;18(1):1-8.

PMID:
12490768
6.

Nefazodone treatment for chronic posttraumatic stress disorder: an open trial.

Davis LL, Nugent AL, Murray J, Kramer GL, Petty F.

J Clin Psychopharmacol. 2000 Apr;20(2):159-64.

PMID:
10770453
7.
8.

Quetiapine treatment in patients with posttraumatic stress disorder: an open trial of adjunctive therapy.

Hamner MB, Deitsch SE, Brodrick PS, Ulmer HG, Lorberbaum JP.

J Clin Psychopharmacol. 2003 Feb;23(1):15-20.

PMID:
12544370
9.

Placebo-controlled trial of risperidone augmentation for selective serotonin reuptake inhibitor-resistant civilian posttraumatic stress disorder.

Rothbaum BO, Killeen TK, Davidson JR, Brady KT, Connor KM, Heekin MH.

J Clin Psychiatry. 2008 Apr;69(4):520-5.

PMID:
18278987
10.

Clinical evaluation of paroxetine in post-traumatic stress disorder (PTSD): 52-week, non-comparative open-label study for clinical use experience.

Kim Y, Asukai N, Konishi T, Kato H, Hirotsune H, Maeda M, Inoue H, Narita H, Iwasaki M.

Psychiatry Clin Neurosci. 2008 Dec;62(6):646-52. doi: 10.1111/j.1440-1819.2008.01862.x.

11.

Treatment of posttraumatic stress disorder with nefazodone.

Davidson JR, Weisler RH, Malik ML, Connor KM.

Int Clin Psychopharmacol. 1998 May;13(3):111-3.

PMID:
9690977
12.

Fluvoxamine treatment in veterans with combat-related post-traumatic stress disorder.

Escalona R, Canive JM, Calais LA, Davidson JR.

Depress Anxiety. 2002;15(1):29-33.

PMID:
11816050
13.

Divalproex in posttraumatic stress disorder: an open-label clinical trial.

Clark RD, CaƱive JM, Calais LA, Qualls CR, Tuason VB.

J Trauma Stress. 1999 Apr;12(2):395-401.

PMID:
10378177
14.

Baclofen treatment for chronic posttraumatic stress disorder.

Drake RG, Davis LL, Cates ME, Jewell ME, Ambrose SM, Lowe JS.

Ann Pharmacother. 2003 Sep;37(9):1177-81.

PMID:
12921495
15.

An open trial of paroxetine in patients with noncombat-related, chronic posttraumatic stress disorder.

Marshall RD, Schneier FR, Fallon BA, Knight CB, Abbate LA, Goetz D, Campeas R, Liebowitz MR.

J Clin Psychopharmacol. 1998 Feb;18(1):10-8.

PMID:
9472837
16.

Can physiologic assessment and side effects tease out differences in PTSD trials? A double-blind comparison of citalopram, sertraline, and placebo.

Tucker P, Potter-Kimball R, Wyatt DB, Parker DE, Burgin C, Jones DE, Masters BK.

Psychopharmacol Bull. 2003 Summer;37(3):135-49.

PMID:
14608246
17.

Treatment of posttraumatic stress disorder with venlafaxine extended release: a 6-month randomized controlled trial.

Davidson J, Baldwin D, Stein DJ, Kuper E, Benattia I, Ahmed S, Pedersen R, Musgnung J.

Arch Gen Psychiatry. 2006 Oct;63(10):1158-65.

PMID:
17015818
18.

[Escitalopram is more effective than citalopram for the treatment of severe major depressive disorder].

Azorin JM, Llorca PM, Despiegel N, Verpillat P.

Encephale. 2004 Mar-Apr;30(2):158-66. French.

PMID:
15107719
19.

A pooled analysis of gender and trauma-type effects on responsiveness to treatment of PTSD with venlafaxine extended release or placebo.

Rothbaum BO, Davidson JR, Stein DJ, Pedersen R, Musgnung J, Tian XW, Ahmed S, Baldwin DS.

J Clin Psychiatry. 2008 Oct;69(10):1529-39.

PMID:
19192435
20.

Comparison of response to a selective serotonin reuptake inhibitor in children, adolescents, and adults with posttraumatic stress disorder.

Seedat S, Stein DJ, Ziervogel C, Middleton T, Kaminer D, Emsley RA, Rossouw W.

J Child Adolesc Psychopharmacol. 2002 Spring;12(1):37-46.

PMID:
12014594

Supplemental Content

Support Center